Rare Disease Action Forum
    • About us
      • Our mission
      • Who we are
      • Board of Directors
      • Members
      • Secretariat
    • Rare Diseases
    • Activities
      • Multi-stakeholder workshops
      • Working Group
      • Other activities
    • Get Involved
    • News
    • Publications
    Select Page

    The RDAF submitted its statement for the public consultation on the ordinances for the revision of the Swiss Invalidity Insurance

    by soxedoze | Mar 19, 2021 | Invalidity Insurance, Publications

    On 19 March 2021, the RDAF submitted its statement to the Federal Social Insurance Office (BSV, Bundesamt für Sozialversicherungen) for the public consultation on the adjustment of various ordinances which are needed to implement the revised Swiss Invalidity Insurance...

    Position paper on IV revision finalized

    by soxedoze | Jul 23, 2018 | Invalidity Insurance, Publications

    Position paper on IV revision finalizedOn 12 July 2018, the Rare Disease Action Forum (RDAF) finalized a position paper on the ongoing revision of the Swiss Invalidity Insurance (IV). The discussions on this issue are ongoing in Parliament, where the Federal...

    The revision of the Swiss invalidity insurance (IV) and its impact on patients with rare diseases

    by soxedoze | May 23, 2018 | Events, Invalidity Insurance

    The Rare Disease Action Forum has organized a multi-stakeholder meeting on the topic of “The revision of the Swiss invalidity insurance (IV) and its impact on patients with rare diseases”, held today in Bern at the Kursaal. Swiss parliamentarians, together with...

    Categories

    • Association
    • BAG/OFSP
    • Events
    • General
    • Invalidity Insurance
    • KVV/OAmal
    • Members
    • Publications
    • Rare Disease Day

    Menu

    • About us
    • Rare Diseases
    • Activities
    • News
    • Publications

    Location

    • Aeschenvorstadt 52
    • 4051 Basel
    • Switzerland

    Contact

    • info@rda-forum.org
    • +41 61 361 9443

    Subscribe

    Thank you very much for subscribing.

    Subscribe

    Terms & Conditions  |  Cookies Policy

    Copyright © All rights reserved